Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Ignace Vergote; B. Lund; H. Havsteen; Z Ujmajuridze; Els Van Nieuwenhuysen; C. Haslund; T. Juhler-Nottrup; Patrick Neven; M. Mau-Sorensen; P. Berteloot; Anne L Kranich; T Rashal; J. Meade; Yosef Landesman; Jean-Richard Saint-Martin; George Wright; M. Crochiere; S Shacham; M Kauffman; M. R. Mirza

doi:10.1093/annonc/mdw374.01

Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Ignace Vergote, B. Lund, H. Havsteen, Z Ujmajuridze, Els Van Nieuwenhuysen, C. Haslund, T. Juhler-Nottrup, Patrick Neven, M. Mau-Sorensen, P. Berteloot, Anne L Kranich, T Rashal, J. Meade, Yosef Landesman, Jean-Richard Saint-Martin, George Wright, M. Crochiere, S Shacham, M Kauffman, M. R. Mirza

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

1 Citation (Scopus)

Original language	English
Article number	8540O
Journal	Annals of Oncology
Volume	27
Issue number	Suppl. 6
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdw374.01
Publication status	Published - 2016
Event	41st ESMO Congress: From disease treatment to patient care - København, Denmark Duration: 7 Oct 2016 → 11 Oct 2016 Conference number: 41 http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress

Conference

Conference	41st ESMO Congress
Number	41
Country/Territory	Denmark
City	København
Period	07/10/2016 → 11/10/2016
Internet address	http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress

Bibliographical note

ISI Document Delivery No.: EK4QS Times Cited: 0 Cited Reference Count: 0 Vergote, I. Lund, B. Havsteen, H. Ujmajuridze, Z. Van Nieuwenhuysen, E. Haslund, C. Juhler-Nottrup, T. Neven, P. Mau-Sorensen, M. Berteloot, P. Kranich, A. Rashal, T. Meade, J. Landesman, Y. Saint-Martin, J-R. Wright, G. Crochiere, M. Shacham, S. Kauffman, M. Mirza, M. Raza Karyopharm Therapeutics 0 Oxford univ press Oxford 1569-8041 6

Keywords

Oncology

Access to Document

10.1093/annonc/mdw374.01

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Vergote, I., Lund, B., Havsteen, H., Ujmajuridze, Z., Van Nieuwenhuysen, E., Haslund, C., Juhler-Nottrup, T., Neven, P., Mau-Sorensen, M., Berteloot, P., Kranich, A. L., Rashal, T., Meade, J., Landesman, Y., Saint-Martin, J-R., Wright, G., Crochiere, M., Shacham, S., Kauffman, M., & Mirza, M. R. (2016). Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers. Annals of Oncology, 27(Suppl. 6), Article 8540O. https://doi.org/10.1093/annonc/mdw374.01

@article{2f1e1628816d47b893e69bd11d1bfed4,

title = "Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers",

keywords = "Oncology",

author = "Ignace Vergote and B. Lund and H. Havsteen and Z Ujmajuridze and {Van Nieuwenhuysen}, Els and C. Haslund and T. Juhler-Nottrup and Patrick Neven and M. Mau-Sorensen and P. Berteloot and Kranich, {Anne L} and T Rashal and J. Meade and Yosef Landesman and Jean-Richard Saint-Martin and George Wright and M. Crochiere and S Shacham and M Kauffman and Mirza, {M. R.}",

note = "ISI Document Delivery No.: EK4QS Times Cited: 0 Cited Reference Count: 0 Vergote, I. Lund, B. Havsteen, H. Ujmajuridze, Z. Van Nieuwenhuysen, E. Haslund, C. Juhler-Nottrup, T. Neven, P. Mau-Sorensen, M. Berteloot, P. Kranich, A. Rashal, T. Meade, J. Landesman, Y. Saint-Martin, J-R. Wright, G. Crochiere, M. Shacham, S. Kauffman, M. Mirza, M. Raza Karyopharm Therapeutics 0 Oxford univ press Oxford 1569-8041 6; 41st ESMO Congress ; Conference date: 07-10-2016 Through 11-10-2016",

year = "2016",

doi = "10.1093/annonc/mdw374.01",

language = "English",

volume = "27",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 6",

url = "http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress",

}

Vergote, I, Lund, B, Havsteen, H, Ujmajuridze, Z, Van Nieuwenhuysen, E, Haslund, C, Juhler-Nottrup, T, Neven, P, Mau-Sorensen, M, Berteloot, P, Kranich, AL, Rashal, T, Meade, J, Landesman, Y, Saint-Martin, J-R, Wright, G, Crochiere, M, Shacham, S, Kauffman, M & Mirza, MR 2016, 'Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers', Annals of Oncology, vol. 27, no. Suppl. 6, 8540O. https://doi.org/10.1093/annonc/mdw374.01

TY - ABST

T1 - Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

AU - Vergote, Ignace

AU - Lund, B.

AU - Havsteen, H.

AU - Ujmajuridze, Z

AU - Van Nieuwenhuysen, Els

AU - Haslund, C.

AU - Juhler-Nottrup, T.

AU - Neven, Patrick

AU - Mau-Sorensen, M.

AU - Berteloot, P.

AU - Kranich, Anne L

AU - Rashal, T

AU - Meade, J.

AU - Landesman, Yosef

AU - Saint-Martin, Jean-Richard

AU - Wright, George

AU - Crochiere, M.

AU - Shacham, S

AU - Kauffman, M

AU - Mirza, M. R.

N1 - Conference code: 41

PY - 2016

Y1 - 2016

KW - Oncology

U2 - 10.1093/annonc/mdw374.01

DO - 10.1093/annonc/mdw374.01

M3 - Conference abstract in journal

SN - 0923-7534

VL - 27

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 6

M1 - 8540O

T2 - 41st ESMO Congress

Y2 - 7 October 2016 through 11 October 2016

ER -